ND PARTNERS LLC has a total of 20 patent applications. Its first patent ever was published in 1999. It filed its patents most often in United States, EPO (European Patent Office) and China. Its main competitors in its focus markets pharmaceuticals, medical technology and basic materials chemistry are MATOKE HOLDINGS LTD, EGASHIRA KENSUKE and CUTANEA LIFE SCIENCES INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | China | 3 | |
#4 | Hong Kong | 3 | |
#5 | Japan | 2 | |
#6 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Basic materials chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Object sterilising | |
#4 | Preservation of human bodies | |
#5 | Syringes |
# | Name | Total Patents |
---|---|---|
#1 | Prosl Frank R | 11 |
#2 | Sodemann Klaus | 4 |
#3 | Estabrook Brian K | 4 |
#4 | Polaschegg Hans-Dietrich | 4 |
#5 | Prosi Frank R | 2 |
#6 | Smith Paul J | 1 |
#7 | Sodemann Kraus | 1 |
#8 | Hans-Dietrich Polaschegg | 1 |
#9 | Frank R Prosl R | 1 |
#10 | Martins Harold M | 1 |
Publication | Filing date | Title |
---|---|---|
JP2012020125A | Biocidal agent lock | |
US2006094690A1 | Antimicrobial locking solutions comprising taurinamide derivatives and biologically acceptable salts and acids, with the addition of small concentrations of heparin | |
HK1059746A1 | Apparatus for overcoming infection in a tissue pocket surrounding an implanted device | |
HK1059535A1 | Antimicrobial locks comprising taurinamide derivatives and carboxylic acids and/or salts thereof | |
US2003225066A1 | Peritoneal dialysis solution with taurolidine | |
US7131962B1 | Port device for subcutaneous access to the vascular system of a patient |